Effectiveness of homoeopathic medicines in the treatment of menopausal hot flushes selected using kents repertory

Effectiveness of homoeopathic medicines in the management of menopausal hot flushes selected using kents repertory: An open, observational, prospective clinical study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055830

Enrollment

Registered

2023-07-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

Intervention1: Homoeopathic medicine after repertorization done using kents Repertory: Patients qualifying to the inclusion criteria will be included in the study. Proper case taking of all enrolled p

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female Patients of age group 40-60 with natural menopause. 2. Female Patients who have amenorrhea since last 12 months on entering menopausal age. 3. Female patients willing to take part in the study and ready to give written consent for the same. 4. Female patients who are able to read, write or understand Bengali or Hindi or English. 5. Female Patients who are having minimum score 10 using Hot Flash Related Daily Interference Scale. 6. Female Patients of all religion and of different socioeconomic status. 7. Female patients with known but controlled systemic diseases

Exclusion criteria

Exclusion criteria: 1. Female Patients who have undergone surgical menopause. 2. Female patients who are having malignant diseases. 3. Female patients using any medicine or hormone therapy containing estrogen and progesterone. 4. Female patients with uncontrolled systemic illness or any organ failure. 5. Female patients suffering from any life threatening/ psychiatric illness or immune compromised state. 6. Female patients who are on substance abuse or dependence. 7. Females who are unwilling to participate in study and not ready to give written consent for the same.

Design outcomes

Primary

Measure	Time frame
The response of the patients suffering from the menopausal hot flushes will be observed on baseline, at 3 rd & 6 th month by using Hot Flash Related Daily Interference scale (HFRDIS). Timepoint: base line, 3rd month, 6th month	—

Secondary

Measure	Time frame
NOT APPLICABLETimepoint: NOT APPLICABLE	—

Countries

India

Contacts

Public ContactDr Lokanath Behera

National institute of homoeopathy

pampulu.behera@gmail.com9477747610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026